SP-0452 Radiotherapy and cisplatin increase immunotherapy efficacy by enabling local and systemic intratumoral T-cell activity

MLA

Ton Nm Schumacher, et al. “SP-0452 Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-Cell Activity.” Radiotherapy and Oncology, vol. 133, Apr. 2019, p. S235. EBSCOhost, https://doi.org/10.1016/s0167-8140(19)30872-2.

APA

Ton Nm Schumacher, Elselien Frijlink, Victoria Iglesias-Guimarais, M. Van Buuren, Paula Kroon, Andriy Volkov, Jannie Borst, Inge Verbrugge, & Marcel Verheij. (2019). SP-0452 Radiotherapy and cisplatin increase immunotherapy efficacy by enabling local and systemic intratumoral T-cell activity. Radiotherapy and Oncology, 133, S235. https://doi.org/10.1016/s0167-8140(19)30872-2

Chicago

Ton Nm Schumacher, Elselien Frijlink, Victoria Iglesias-Guimarais, M. Van Buuren, Paula Kroon, Andriy Volkov, Jannie Borst, Inge Verbrugge, and Marcel Verheij. 2019. “SP-0452 Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-Cell Activity.” Radiotherapy and Oncology 133 (April): S235. doi:10.1016/s0167-8140(19)30872-2.